Source: Pathophysiology. Unidade: FMRP
Subjects: FERTILIDADE, NEOPLASIAS, GONADOTROFINAS, OVÁRIO, QUALIDADE DE VIDA, FARMACOTERAPIA
ABNT
BEDOSCHI, Giuliano Marchetti e INGOLD, Caroline e NAVARRO, Paula Andrea de Albuquerque Salles. Fertility preservation and ovarian hyperstimulation syndrome management in cancer care: a pathophysiological perspective on gonadotropin-releasing hormone agonists and antagonists. Pathophysiology, v. 31, n. 2, p. 288-297, 2024Tradução . . Disponível em: https://doi.org/10.3390/pathophysiology31020021. Acesso em: 24 fev. 2026.APA
Bedoschi, G. M., Ingold, C., & Navarro, P. A. de A. S. (2024). Fertility preservation and ovarian hyperstimulation syndrome management in cancer care: a pathophysiological perspective on gonadotropin-releasing hormone agonists and antagonists. Pathophysiology, 31( 2), 288-297. doi:10.3390/pathophysiology31020021NLM
Bedoschi GM, Ingold C, Navarro PA de AS. Fertility preservation and ovarian hyperstimulation syndrome management in cancer care: a pathophysiological perspective on gonadotropin-releasing hormone agonists and antagonists [Internet]. Pathophysiology. 2024 ; 31( 2): 288-297.[citado 2026 fev. 24 ] Available from: https://doi.org/10.3390/pathophysiology31020021Vancouver
Bedoschi GM, Ingold C, Navarro PA de AS. Fertility preservation and ovarian hyperstimulation syndrome management in cancer care: a pathophysiological perspective on gonadotropin-releasing hormone agonists and antagonists [Internet]. Pathophysiology. 2024 ; 31( 2): 288-297.[citado 2026 fev. 24 ] Available from: https://doi.org/10.3390/pathophysiology31020021
